CureVac’s mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial. By BY CARL ZIMMER from NYT Health https://ift.tt/2S3JZhJ via IFTTT Related Posts: Tweet
0 Response to "CureVac’s mRNA vaccine reaches an efficacy level of just 47 percent in a clinical trial."
Post a Comment